{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:10:50Z","timestamp":1780722650841,"version":"3.54.1"},"reference-count":119,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2014.00309","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T10:42:46Z","timestamp":1408444966000},"source":"Crossref","is-referenced-by-count":50,"title":["Hypertrophic cardiomyopathy: a heart in need of an energy bar?"],"prefix":"10.3389","volume":"5","author":[{"given":"Styliani","family":"Vakrou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Roselle","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ncpcardio0583","article-title":"Modification of myocardial substrate use as a therapy for heart failure","volume":"3","author":"Abozguia","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.amjcard.2013.05.017","article-title":"Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy","volume":"112","author":"Abraham","year":"2013","journal-title":"Am. J. Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1529\/biophysj.103.039131","article-title":"Cardiac length dependence of force and force redevelopment kinetics with altered cross-bridge cycling","volume":"87","author":"Adhikari","year":"2004","journal-title":"Biophys. J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1172\/JCI25371","article-title":"The mitochondrial origin of postischemic arrhythmias","volume":"115","author":"Akar","year":"2005","journal-title":"J. Clin. Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbadis.2005.06.008","article-title":"Mitochondrial criticality: a new concept at the turning point of life or death","volume":"1762","author":"Aon","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"B7","doi-asserted-by":"publisher","first-page":"44735","DOI":"10.1074\/jbc.M302673200","article-title":"Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes","volume":"278","author":"Aon","year":"2003","journal-title":"J. Biol. Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1161\/CIRCRESAHA.111.242974","article-title":"Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy","volume":"109","author":"Ashrafian","year":"2011","journal-title":"Circ. Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0168-9525(03)00081-7","article-title":"Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion","volume":"19","author":"Ashrafian","year":"2003","journal-title":"Trends Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.bbabio.2009.05.011","article-title":"The role of Ca(2+) signaling in the coordination of mitochondrial atp production with cardiac work","volume":"1787","author":"Balaban","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11906-010-0149-8","article-title":"Mitochondrial dysfunction and oxidative damage to sarcomeric proteins","volume":"12","author":"Bayeva","year":"2010","journal-title":"Curr. Hypertens. Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/hmg\/10.11.1215","article-title":"Mutations in the gamma(2) subunit of amp-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis","volume":"10","author":"Blair","year":"2001","journal-title":"Hum. Mol. Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/01.RES.84.4.475","article-title":"Altered crossbridge kinetics in the alphamhc403\/+ mouse model of familial hypertrophic cardiomyopathy","volume":"84","author":"Blanchard","year":"1999","journal-title":"Circ. Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2967\/jnumed.111.096156","article-title":"Pet\/Ct assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"53","author":"Bravo","year":"2012","journal-title":"J. Nucl. Med"},{"key":"B17","first-page":"221","article-title":"Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis","volume":"106","author":"Brock","year":"1957","journal-title":"Guys. Hosp. Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/hrt.26.1.16","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"26","author":"Cohen","year":"1964","journal-title":"Br. Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1529\/biophysj.105.076174","article-title":"A computational model integrating electrophysiology, contraction, and mitochondrial bioenergetics in the ventricular myocyte","volume":"91","author":"Cortassa","year":"2006","journal-title":"Biophys. J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbabio.2013.11.007","article-title":"Redox-optimized ros balance and the relationship between mitochondrial respiration and ros","volume":"1837","author":"Cortassa","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J. Am. Coll. Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/heartjnl-2013-304914","article-title":"Cardiac output response and peripheral oxygen extraction during exercise among symptomatic hypertrophic cardiomyopathy patients with and without left ventricular outflow tract obstruction","volume":"100","author":"Critoph","year":"2014","journal-title":"Heart"},{"key":"B24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1734-1140(09)70091-X","article-title":"Enhanced oxidative stress in hypertrophic cardiomyopathy","volume":"61","author":"Dimitrow","year":"2009","journal-title":"Pharmacol. Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(04)16358-7","article-title":"Hypertrophic cardiomyopathy","volume":"363","author":"Elliott","year":"2004","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"18219","DOI":"10.1073\/pnas.0509181102","article-title":"Changes in the chemical and dynamic properties of cardiac troponin t cause discrete cardiomyopathies in transgenic mice","volume":"102","author":"Ertz-Berger","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1089\/ars.2012.4729","article-title":"Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health","volume":"18","author":"Figueira","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.110.950089","article-title":"Research priorities in hypertrophic cardiomyopathy: report of a working group of the national heart, lung, and blood institute","volume":"122","author":"Force","year":"2010","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1172\/JCI5220","article-title":"Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy","volume":"103","author":"Gao","year":"1999","journal-title":"J. Clin. Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/CIRCRESAHA.111.300193","article-title":"Genetic inhibition of Na+-Ca2+ exchanger current disables fight or flight sinoatrial node activity without affecting resting heart rate","volume":"112","author":"Gao","year":"2013","journal-title":"Circ. Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.bpj.2013.11.007","article-title":"An integrated mitochondrial ros production and scavenging model: implications for heart failure","volume":"105","author":"Gauthier","year":"2013","journal-title":"Biophys. J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/6549","article-title":"The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation","volume":"5","author":"Georgakopoulos","year":"1999","journal-title":"Nat. Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"E212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 Accf\/Aha guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the american college of cardiology foundation\/american heart association task force on practice guidelines. developed in collaboration with the american association for thoracic surgery, american society of echocardiography, American society of nuclear cardiology, heart failure society of america, heart rhythm society, society for cardiovascular angiography and interventions, and society of thoracic surgeons","volume":"58","author":"Gersh","year":"2011","journal-title":"J. Am. Coll. Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"17403","DOI":"10.1073\/pnas.1009619107","article-title":"Cardiomyopathy-linked myosin regulatory light chain mutations disrupt myosin strain-dependent biochemistry","volume":"107","author":"Greenberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.yjmcc.2008.09.126","article-title":"Regulatory light chain mutations associated with cardiomyopathy affect myosin mechanics and kinetics","volume":"46","author":"Greenberg","year":"2009","journal-title":"J. Mol. Cell. Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0735-1097(89)90505-6","article-title":"Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"13","author":"Grover-McKay","year":"1989","journal-title":"J. Am. Coll. Cardiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu154","article-title":"Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy","author":"Gruner","year":"2014","journal-title":"Eur. Heart J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"H614","DOI":"10.1152\/ajpheart.01143.2008","article-title":"Temporal and mutation-specific alterations in ca2+ homeostasis differentially determine the progression of Ctnt-related cardiomyopathies in murine models","volume":"297","author":"Guinto","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1006893903113","article-title":"Role of mitochondrial calcium transport in the control of substrate oxidation","volume":"184","author":"Hansford","year":"1998","journal-title":"Mol. Cell. Biochem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/01.CIR.103.5.670","article-title":"Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure","volume":"103","author":"Haq","year":"2001","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1529\/biophysj.107.107557","article-title":"R-92l And R-92w mutations in cardiac troponin t lead to distinct energetic phenotypes in intact mouse hearts","volume":"93","author":"He","year":"2007","journal-title":"Biophys. J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"37183","DOI":"10.1074\/jbc.M508114200","article-title":"F110i And R278c troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers","volume":"280","author":"Hernandez","year":"2005","journal-title":"J. Biol. Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1242\/dmm.010900","article-title":"Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's Ataxia","volume":"6","author":"Hick","year":"2013","journal-title":"Dis. Model. Mech"},{"key":"B45","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc. Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJM198911163212005","article-title":"Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1","volume":"321","author":"Jarcho","year":"1989","journal-title":"N. Engl. J. Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1172\/JCI15967","article-title":"Decreased energetics in murine hearts bearing the R92q mutation in cardiac troponin T","volume":"112","author":"Javadpour","year":"2003","journal-title":"J. Clin. Invest"},{"key":"B49","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1161\/01.CIR.101.12.e121","article-title":"Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy","volume":"101","author":"Jung","year":"2000","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1161\/01.CIR.97.25.2536","article-title":"31p Nmr spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy","volume":"97","author":"Jung","year":"1998","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bpj.2012.11.3808","article-title":"Integrating mitochondrial energetics, redox and ros metabolic networks: a two-compartment model","volume":"104","author":"Kembro","year":"2013","journal-title":"Biophys. J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ncpcardio1110","article-title":"Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression","volume":"5","author":"Keren","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.109.914911","article-title":"Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes","volume":"121","author":"Kohlhaas","year":"2010","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin Ii blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s12265-013-9481-0","article-title":"Electromechanical relationship in hypertrophic cardiomyopathy","volume":"6","author":"Lin","year":"2013","journal-title":"J. Cardiovasc. Transl. Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCRESAHA.108.175919","article-title":"Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching","volume":"103","author":"Liu","year":"2008","journal-title":"Circ. Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"31984","DOI":"10.1074\/jbc.M113.496588","article-title":"Regulation of the Na+\/Ca2+ exchanger by pyridine nucleotide redox potential in ventricular myocytes","volume":"288","author":"Liu","year":"2013","journal-title":"J. Biol. Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCRESAHA.115.303062","article-title":"Inhibiting mitochondrial Na+\/Ca2+ exchange prevents sudden death in a guinea pig model of heart failure","volume":"115","author":"Liu","year":"2014","journal-title":"Circ. Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","article-title":"Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms","volume":"119","author":"Lombardi","year":"2009","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"H575","DOI":"10.1152\/ajpheart.00619.2002","article-title":"Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy","volume":"284","author":"Lucas","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/01.RES.0000232546.92777.05","article-title":"Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes","volume":"99","author":"Maack","year":"2006","journal-title":"Circ. Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00395-007-0666-z","article-title":"Excitation-contraction coupling and mitochondrial energetics","volume":"102","author":"Maack","year":"2007","journal-title":"Basic Res. Cardiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00001573-200205000-00006","article-title":"Modifier genes for hypertrophic cardiomyopathy","volume":"17","author":"Marian","year":"2002","journal-title":"Curr. Opin. Cardiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1006\/jmcc.2001.1340","article-title":"The molecular genetic basis for hypertrophic cardiomyopathy","volume":"33","author":"Marian","year":"2001","journal-title":"J. Mol. Cell. Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2005.10.041","article-title":"Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation","volume":"47","author":"Marian","year":"2006","journal-title":"J. Am. Coll. Cardiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"B68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J. Am. Coll. Cardiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"239ps6","DOI":"10.1126\/scitranslmed.3008921","article-title":"Human stem cells for modeling heart disease and for drug discovery","volume":"6","author":"Matsa","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCGENETICS.108.808329","article-title":"Metabolomics: ready for the prime time?","volume":"1","author":"Mayr","year":"2008","journal-title":"Circ. Cardiovasc. Genet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0005-2728(90)90269-A","article-title":"The role of mitochondrial Ca2+ transport and matrix Ca2+ in signal transduction in mammalian tissues","volume":"1018","author":"McCormack","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"B74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jtbi.2011.06.014","article-title":"Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58q mutation in the regulatory light chain of myosin","volume":"284","author":"Mettikolla","year":"2011","journal-title":"J. Theor. Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1365-2362.2010.02349.x","article-title":"Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study","volume":"40","author":"Nagueh","year":"2010","journal-title":"Eur. J. Clin. Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cardfail.2004.05.005","article-title":"Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy","volume":"11","author":"Nakamura","year":"2005","journal-title":"J. Card. Fail"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.87.5.1580","article-title":"Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy","volume":"87","author":"Nienaber","year":"1993","journal-title":"Circulation"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0002-8703(92)90410-W","article-title":"Point mutations in mitochondrial dna in patients with hypertrophic cardiomyopathy","volume":"124","author":"Obayashi","year":"1992","journal-title":"Am. Heart J"},{"key":"B79","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/hrt.80.3.292","article-title":"A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (melas)","volume":"80","author":"Okajima","year":"1998","journal-title":"Heart"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1093\/eurheartj\/ehp307","article-title":"Sudden cardiac death risk in hypertrophic cardiomyopathy","volume":"30","author":"Ommen","year":"2009","journal-title":"Eur. Heart J"},{"key":"B81","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1152\/physiol.00020.2005","article-title":"Mitochondrial ion channels: gatekeepers of life and death","volume":"20","author":"O'Rourke","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0002-9149(93)90160-E","article-title":"Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy","volume":"72","author":"Perrone-Filardi","year":"1993","journal-title":"Am. J. Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S0008-6363(02)00841-6","article-title":"[Na+]I Handling in the failing human heart","volume":"57","author":"Pieske","year":"2003","journal-title":"Cardiovasc. Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.abb.2014.01.019","article-title":"Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes","volume":"552\u00e2\u20ac\u201c553","author":"Puglisi","year":"2014","journal-title":"Arch. Biochem. Biophys"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/CIRCRESAHA.107.156380","article-title":"Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments","volume":"101","author":"Robinson","year":"2007","journal-title":"Circ. Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.CIR.34.4.558","article-title":"The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis","volume":"34","author":"Ross","year":"1966","journal-title":"Circulation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron-sulphur protein deficiency in friedreich ataxia","volume":"17","author":"Rotig","year":"1997","journal-title":"Nat. Genet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1113\/jphysiol.2005.101444","article-title":"Cardiac system bioenergetics: metabolic basis of the frank-starling law","volume":"571","author":"Saks","year":"2006","journal-title":"J. Physiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/hrt.2005.068270","article-title":"Oxidative stress and redox signalling in cardiac hypertrophy and heart failure","volume":"93","author":"Seddon","year":"2007","journal-title":"Heart"},{"key":"B90","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1172\/JCI200214677","article-title":"The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model","volume":"109","author":"Semsarian","year":"2002","journal-title":"J. Clin. Invest"},{"key":"B92","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/01.RES.0000177090.07296.ac","article-title":"Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"97","author":"Senthil","year":"2005","journal-title":"Circ. Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jchf.2013.09.001","article-title":"Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy","volume":"1","author":"Shimada","year":"2013","journal-title":"JACC Heart Fail"},{"key":"B94","doi-asserted-by":"publisher","first-page":"I102","DOI":"10.1007\/s003950200038","article-title":"Molecular mechanisms of cardiac myofilament activation: modulation by ph and a troponin t mutant R92q","volume":"97","author":"Solaro","year":"2002","journal-title":"Basic Res. Cardiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI114802","article-title":"Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease","volume":"86","author":"Solomon","year":"1990","journal-title":"J. Clin. Invest"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1172\/JCI1940","article-title":"Diastolic dysfunction and altered energetics in the Alphamhc403\/+ mouse model of familial hypertrophic cardiomyopathy","volume":"101","author":"Spindler","year":"1998","journal-title":"J. Clin. Invest"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/bmj.332.7552.1251","article-title":"Management of hypertrophic cardiomyopathy","volume":"332","author":"Spirito","year":"2006","journal-title":"BMJ"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors","volume":"113","author":"Spirito","year":"2014","journal-title":"Am. J. Cardiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence","volume":"33","author":"Spoladore","year":"2012","journal-title":"Eur. Heart J"},{"key":"B101","doi-asserted-by":"publisher","first-page":"33669","DOI":"10.1074\/jbc.M111.284612","article-title":"Thioredoxin reductase-2 is essential for keeping low levels of H(2)O(2) emission from isolated heart mitochondria","volume":"286","author":"Stanley","year":"2011","journal-title":"J. Biol. Chem"},{"key":"B102","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1073\/pnas.91.2.589","article-title":"Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy","volume":"91","author":"Straceski","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1126\/science.281.5383.1690","article-title":"Prevention of cardiac hypertrophy in mice by calcineurin inhibition","volume":"281","author":"Sussman","year":"1998","journal-title":"Science"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M307092200","article-title":"Familial hypertrophic cardiomyopathy-linked alterations In Ca2+ binding of human cardiac myosin regulatory light chain affect cardiac muscle contraction","volume":"279","author":"Szczesna-Cordary","year":"2004","journal-title":"J. Biol. Chem"},{"key":"B105","first-page":"572","article-title":"Myocardial metabolic changes in hypertrophic cardiomyopathy","volume":"37","author":"Tadamura","year":"1996","journal-title":"J. Nucl. Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1172\/JCI6067","article-title":"Cardiac troponin t mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy","volume":"104","author":"Tardiff","year":"1999","journal-title":"J. Clin. Invest"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/hrt.20.1.1","article-title":"Asymmetrical hypertrophy of the heart in young adults","volume":"20","author":"Teare","year":"1958","journal-title":"Br. Heart J"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-Beta","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J. Clin. Invest"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.108.184457","article-title":"Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure","volume":"103","author":"Terentyev","year":"2008","journal-title":"Circ. Res"},{"key":"B110","doi-asserted-by":"crossref","first-page":"C423","DOI":"10.1152\/ajpcell.2000.278.2.C423","article-title":"Ca(2+) Activation of heart mitochondrial oxidative phosphorylation: role of the F(0)\/F(1)-Atpase","volume":"278","author":"Territo","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0092-8674(94)90054-X","article-title":"Alpha-tropomyosin and cardiac troponin t mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere","volume":"77","author":"Thierfelder","year":"1994","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/eurjhf\/hfr135","article-title":"Carriers of the hypertrophic cardiomyopathy Mybpc3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction","volume":"13","author":"Timmer","year":"2011","journal-title":"Eur. J. Heart Fail"},{"key":"B113","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nuclcard.2006.12.329","article-title":"Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the asp175asn mutation in the alpha-tropomyosin gene: a positron emission tomography study","volume":"14","author":"Tuunanen","year":"2007","journal-title":"J. Nucl. Cardiol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/eurheartj\/ehp184","article-title":"Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"30","author":"Unno","year":"2009","journal-title":"Eur. Heart J"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies","volume":"364","author":"Watkins","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng0493-333","article-title":"A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3","volume":"3","author":"Watkins","year":"1993","journal-title":"Nat. Genet"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.bpj.2009.07.029","article-title":"Modeling cardiac action potential shortening driven by oxidative stress-induced mitochondrial oscillations in guinea Pig cardiomyocytes","volume":"97","author":"Zhou","year":"2009","journal-title":"Biophys. J"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.192.7.1001","article-title":"Reactive oxygen species (ros)-induced ros release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes","volume":"192","author":"Zorov","year":"2000","journal-title":"J. Exp. Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbabio.2006.04.029","article-title":"Mitochondrial ros-induced ros release: an update and review","volume":"1757","author":"Zorov","year":"2006","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T03:34:26Z","timestamp":1565753666000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphys.2014.00309\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,19]]},"references-count":119,"URL":"https:\/\/doi.org\/10.3389\/fphys.2014.00309","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,19]]}}}